250 related articles for article (PubMed ID: 6286514)
21. Paired Epstein-Barr virus-carrying lymphoma and lymphoblastoid cell lines from Burkitt's lymphoma patients: comparative sensitivity to non-specific and to allo-specific cytotoxic responses in vitro.
Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
Int J Cancer; 1984 Sep; 34(3):339-48. PubMed ID: 6090321
[TBL] [Abstract][Full Text] [Related]
22. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. IV. Differentiation between antibodies responsible for membrane and viral immunofluorescence.
Pearson G; Klein G; Henle G; Henle W; Clifford P
J Exp Med; 1969 Apr; 129(4):707-18. PubMed ID: 4886045
[TBL] [Abstract][Full Text] [Related]
23. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992
[TBL] [Abstract][Full Text] [Related]
24. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype.
Falk MH; Trauth BC; Debatin KM; Klas C; Gregory CD; Rickinson AB; Calender A; Lenoir GM; Ellwart JW; Krammer PH
Blood; 1992 Jun; 79(12):3300-6. PubMed ID: 1375849
[TBL] [Abstract][Full Text] [Related]
25. IL6 and IL6 receptor expression in Burkitt's lymphoma and lymphoblastoid cell lines: promotion of IL6 receptor expression by EBV.
Klein SC; Jücker M; Abts H; Tesch H
Hematol Oncol; 1995; 13(3):121-30. PubMed ID: 7622142
[TBL] [Abstract][Full Text] [Related]
26. Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.
Wolf J; Draube A; Bohlen H; Jox A; Mücke S; Pawlita M; Möller P; Diehl V
Int J Cancer; 1995 Feb; 60(4):527-33. PubMed ID: 7829268
[TBL] [Abstract][Full Text] [Related]
27. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells.
Rowe M; Rowe DT; Gregory CD; Young LS; Farrell PJ; Rupani H; Rickinson AB
EMBO J; 1987 Sep; 6(9):2743-51. PubMed ID: 2824192
[TBL] [Abstract][Full Text] [Related]
28. [A monoclonal antibody, specific for Burkitt's lymphoma, is also a blood group Pk antibody].
Fellous M; Wiels J; Cartron JP; Tursz T
Dev Biol Stand; 1984; 57():293-8. PubMed ID: 6084615
[TBL] [Abstract][Full Text] [Related]
29. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
Khanna R; Burrows SR; Suhrbier A; Jacob CA; Griffin H; Misko IS; Sculley TB; Rowe M; Rickinson AB; Moss DJ
J Immunol; 1993 Jun; 150(11):5154-62. PubMed ID: 7684421
[TBL] [Abstract][Full Text] [Related]
30. Diploid human lymphoblastoid and Burkitt lymphoma cell lines: susceptibility to murine NK cells and heterotransplantation to nude mice.
McCormick KH; Giovanella BC; Klein G; Nilsson K; Stehlin JS
Int J Cancer; 1981 Oct; 28(4):455-8. PubMed ID: 6273332
[TBL] [Abstract][Full Text] [Related]
31. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
[TBL] [Abstract][Full Text] [Related]
32. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
Klein G; Ehlin-Henriksson B; Schlossman SF
J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
[TBL] [Abstract][Full Text] [Related]
33. Characterization of a novel Burkitt's lymphoma-associated antigen: GP70. Reactivity of anti-GP70 antibodies with various malignant and non-malignant cell lines.
Gazitt Y; Lerner A; Ben-Bassat H
Immunol Lett; 1986 Jan; 12(1):43-50. PubMed ID: 3007337
[TBL] [Abstract][Full Text] [Related]
34. Development and characterization of a human monoclonal antibody probably detecting the leukocyte differentiation antigen CD39.
Ikewaki N; Takabe S; Tsuji K
Tissue Antigens; 1992 Apr; 39(4):174-81. PubMed ID: 1326791
[TBL] [Abstract][Full Text] [Related]
35. Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines.
Rooney CM; Gregory CD; Rowe M; Finerty S; Edwards C; Rupani H; Rickinson AB
J Natl Cancer Inst; 1986 Sep; 77(3):681-7. PubMed ID: 2943927
[TBL] [Abstract][Full Text] [Related]
36. Establishment and characterization of an Epstein-Barr virus (EBC)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma.
Menezes J; Leibold W; Klein G; Clements G
Biomedicine; 1975 Jul; 22(4):276-84. PubMed ID: 179629
[TBL] [Abstract][Full Text] [Related]
37. Monoclonal antibody against a Burkitt lymphoma-associated antigen.
Wiels J; Fellous M; Tursz T
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6485-8. PubMed ID: 7031655
[TBL] [Abstract][Full Text] [Related]
38. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
[TBL] [Abstract][Full Text] [Related]
39. 38.13: a monoclonal antibody directed against a Burkitt's lymphoma-associated antigen and its use as carrier for toxins.
Wiels J; Balaña A; Tursz T
IARC Sci Publ; 1985; (60):457-64. PubMed ID: 4065950
[TBL] [Abstract][Full Text] [Related]
40. Distinction between Burkitt lymphoma subgroups by monoclonal antibodies: relationships between antigen expression and type of chromosomal translocation.
Ehlin-Henriksson B; Klein G
Int J Cancer; 1984 Apr; 33(4):459-63. PubMed ID: 6231253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
